Viewing StudyNCT05770713



Ignite Creation Date: 2024-05-06 @ 6:45 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05770713
Status: COMPLETED
Last Update Posted: 2023-04-21
First Post: 2023-03-05

Brief Title: A Real-life Study to Learn About the Use and Effects of the CDK46 Inhibitors in Canadian Patients With Breast Cancer
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2023-02-28
Primary Completion Date Type: ACTUAL
Completion Date: 2023-02-28
Completion Date Type: ACTUAL
First Submit Date: 2023-03-05
First Submit QC Date: March 5 2023
Study First Post Date: 2023-03-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-07
Last Update Post Date: 2023-04-21
Last Update Post Date Type: ACTUAL